Previously, it has been shown that nuclear S100A4 from adenocarcinomas of the colon or rectum is a negative predictor of disease-free and overall survival whereas cytoplasmic S100A4 was not associated with patient outcome [43]. Here, S100A4 is linked to adenocarcinoma.